Equity Strategy • 28 Sept 2026
Innovative Drug Sector: Cancer Vaccine Breakthrough
Cancer vaccine sees breakthrough. On 19 Aug 2026, Moderna and Merck announced positive results from the Phase 3 INTerpath-001 trial which evaluated Intismeran, which is a personalised mRNA-based ther...